|
ALLK
|
Allakos Inc.
|
0.83%
|
US
|
NASDAQ
|
|
PLRX
|
Pliant Therapeutics, Inc.
|
0.82%
|
US
|
NASDAQ
|
|
CDXS
|
Codexis, Inc.
|
0.82%
|
US
|
NASDAQ
|
|
VIR
|
Vir Biotechnology, Inc.
|
0.82%
|
US
|
NASDAQ
|
|
PCVX
|
Vaxcyte, Inc.
|
0.81%
|
US
|
NASDAQ
|
|
AKRO
|
Akero Therapeutics, Inc.
|
0.81%
|
US
|
NASDAQ
|
|
STOK
|
Stoke Therapeutics, Inc.
|
0.80%
|
US
|
NASDAQ
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
0.80%
|
US
|
NASDAQ
|
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
0.79%
|
US
|
NASDAQ
|
|
XENE
|
Xenon Pharmaceuticals Inc.
|
0.77%
|
US
|
NASDAQ
|
|
MORF
|
Morphic Holding, Inc.
|
0.77%
|
US
|
NASDAQ
|
|
KRYS
|
Krystal Biotech, Inc.
|
0.77%
|
US
|
NASDAQ
|
|
XNCR
|
Xencor, Inc.
|
0.76%
|
US
|
NASDAQ
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
0.76%
|
US
|
NASDAQ
|
|
KRTX
|
Karuna Therapeutics, Inc.
|
0.76%
|
US
|
NASDAQ
|
|
BCYC
|
Bicycle Therapeutics plc
|
0.76%
|
US
|
NASDAQ
|
|
ALXO
|
ALX Oncology Holdings Inc.
|
0.76%
|
US
|
NASDAQ
|
|
ABCL
|
AbCellera Biologics Inc.
|
0.76%
|
US
|
NASDAQ
|
|
ZNTL
|
Zentalis Pharmaceuticals, Inc.
|
0.75%
|
US
|
NASDAQ
|
|
SRNE
|
Sorrento Therapeutics, Inc.
|
0.75%
|
US
|
NASDAQ
|